project id: TCGA-OV; case submitter id: TCGA-09-2053; selected normal wgs: true; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 7.0; spectrophotometer method: UV Spec; age at index: 72; days to birth: -26433; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1933; age at diagnosis: 26433; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1209.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; portion number: 01; weight: 109.0; composition: Not Reported; intermediate dimension: 0.4; longest dimension: 0.7; preservation method: Unknown; shortest dimension: 0.3; sample id: 9236e7c0-7b03-4bed-9f19-e3cf805be49b; sample submitter id: TCGA-09-2053-01C; portion id: 0e6ff3e8-b75a-4bc3-b69d-7b875bf613a2; portion submitter id: TCGA-09-2053-01C-01; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0;